Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
JCI Insight|December 9, 2025
Thrombomodulin protects against acute vascular and multiorgan injury in Sickle Cell diseaseGuohui Ren, Dustin R Fraidenburg, Suman Setty, et al.
Blood|June 1, 2026
Renin-Angiotensin-Aldosterone System Inhibition Exacerbates Anemia in Sickle Cell DiseaseNajmeh Eskandari, Emma Pappano, Maria Armila D Ruiz, et al.
Blood Advances|June 13, 2022
Longitudinal study of glomerular hyperfiltration in adults with sickle cell anemia: a multicenter pooled analysisKenneth I Ataga, Qingning Zhou, Santosh L Saraf, et al.
Scientific Reports|August 8, 2023
Gene expression changes in sickle cell reticulocytes and their clinical associationsXu Zhang, Jihyun Song, Binal N Shah, et al.
Leukemia & Lymphoma|October 26, 2017
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myelomaPritesh Patel, Annie L Oh, Matthew Koshy, et al.
Kidney360|October 29, 2020
Anemia and Incident End-Stage Kidney DiseaseSantosh L Saraf, Jesse Y Hsu, Ana C Ricardo, et al.
Blood Advances|April 29, 2025
Chronic kidney disease in adults with sickle cell trait: A systematic review and meta-analysisYagahira Castro Sesquen, Carmela Gelida Barboza Justiniano, Diego J Aparcana-Granda, et al.
Blood Advances|September 5, 2017
Associations of α-thalassemia and BCL11A with stroke in Nigerian, United States, and United Kingdom sickle cell anemia cohortsSantosh L Saraf, Titilola S Akingbola, Binal N Shah, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 11, 2022
Black and White Adults With CKD Hospitalized With Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyAnthony N Muiru, Jingrong Yang, Vimal K Derebail, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 20, 2014
Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I studyPritesh Patel, Bulent Aydogan, Matthew Koshy, et al.
Pageof 8